Showing results (101-110 of 133) with videos related to
Sort By:
Pageof 14
Blood|January 1, 1978
Hairy-cell leukemia with T-cell featuresJ C Cawley, G F Burns, T A Nash, et al.Cytokine|May 1, 1995
Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevanceD Clarke, O Katoh, R V Gibbs, et al.Clinical and Experimental Immunology|March 1, 1978
Differing surface marker characteristics in plasma cell dyscrasias with particular reference to IgM myelomaG F Burns, J C Cawley, C R Barker, et al.British Journal of Haematology|April 1, 1993
The peanut-agglutinin (PNA)-binding surface components of malignant plasma cellsJ R Slupsky, M Duggan-Keen, L A Booth, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Endolymphatic delivery of IL2 in patients with melanoma and lymphomaD W Galvani, S Walton, J M Davies, et al.Acta Haematologica|January 1, 1992
Combination of GM-CSF and cytosine in myelodysplasia results in improved neutrophil functionD W Galvani, Y Dang, F Watson, et al.Blood|October 26, 2000
In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cellsH Chen, A T Treweeke, D C West, et al.Cancer|September 1, 1979
Chronic myelomonocytic leukemia with paraproteinemia but no detectable plasmacytosis: a detailed cytological and immunological studyD L Barnard, G F Burns, J Gordon, et al.Geomorphology (Amsterdam, Netherlands)|November 17, 2021
Inverted channel variations identified on a distal portion of a bajada in the central Atacama Desert, ChileRebecca M E Williams, Rossman P Irwin, Eldar Z Noe Dobrea, et al.Leukemia & Lymphoma|May 1, 1995
A randomized study of MOD versus VAD in the treatment of relapsed and resistant multiple myelomaJ K Phillips, C Sherlaw-Johnson, R Pearce, et al.Pageof 14